Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, December 2001, p. 3657-3659, Vol. 45, No. 12
Division of Neurology and Department of
Microbiology and Immunology, The Pennsylvania State University
College of Medicine, Hershey, Pennsylvania 17033
Received 16 April 2001/Returned for modification 12 July
2001/Accepted 27 August 2001
Herpes simplex virus (HSV) reactivation from latency was
investigated. Reactivation of thymidine kinase-negative HSV, which is
defective for reactivation, was greatly enhanced by thymidine (TdR).
The reactivation-enhancing effect of TdR was blocked by dipyridamole
(DPM), a known nucleoside transport inhibitor. DPM also inhibited
wild-type HSV reactivation, suggesting potential antiviral use.
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.12.3657-3659.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Inhibition of Herpes Simplex Virus Reactivation by
Dipyridamole
*
Corresponding author. Mailing address: Division of
Neurology, 500 University Dr., Hershey, PA 17033. Phone: (717)
531-8692. Fax: (717) 531-4694. E-mail: rtenser{at}psu.edu.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |